Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Valentina Drago"'
Autor:
Valentina Drago, Federica Giuffrida
Publikováno v:
AboutOpen, Vol 10, Iss 1 (2023)
Law 648 has been introduced in Italy in 1996. It allows early access and off label use of novel drugs that fulfill important unmet medical needs. Despite being live for almost twenty years, there are still several areas where the clinician does not h
Externí odkaz:
https://doaj.org/article/e871ed461fa7419e8ab4d1a413b2871f
Autor:
Valentina Drago, Luisa Di Paola, Claire Lesieur, Renato Bernardini, Claudio Bucolo, Chiara Bianca Maria Platania
Publikováno v:
Applied Sciences, Vol 12, Iss 15, p 7855 (2022)
Factor VIII belongs to the coagulation cascade and is expressed as a long pre-protein (mature form, 2351 amino acids long). FVIII is deficient or defective in hemophilic A patients, who need to be treated with hemoderivatives or recombinant FVIII sub
Externí odkaz:
https://doaj.org/article/e5427649747d47f5ac9ecef345cd828a
Autor:
Filippo Drago, Laura Longo, Valentina Drago, Salvatore Salomone, Americo Cicchetti, Andrea Navarria, Lucia Gozzo, Giacomo Pignataro, S. Mansueto
Publikováno v:
Clinical drug investigation. 36(7)
Appropriate pricing of medications is one of the ultimate goals for decision makers, but reliable data on the risk/benefit ratio are often lacking when a Marketing Authorization Application is submitted. Here we propose a method to consistently evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215d23d7e4f03f279b3a951823bbcbff
https://pubmed.ncbi.nlm.nih.gov/27153824
https://pubmed.ncbi.nlm.nih.gov/27153824
Autor:
Cristina Travelli, Fabio Di Lisa, Gian Cesare Tron, Pier Luigi Canonico, Nina Kaludercic, Armando A. Genazzani, Valentina Drago, Ubaldina Galli, Elena Maldi, Renzo Boldorini
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 338:829-840
NAD is an essential coenzyme involved in numerous metabolic pathways. Its principal role is in redox reactions, and as such it is not heavily "consumed" by cells. Yet a number of signaling pathways that bring about its consumption have recently emerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a34cd5b016b2f2b573fe26869df3e3a
https://doi.org/10.1124/jpet.111.184630
https://doi.org/10.1124/jpet.111.184630
Autor:
Filippo Drago, Andrea Navarria, Lucia Gozzo, Valentina Drago, Giacomo Pignataro, Laura Longo, S. Mansueto
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710411ff512bc70d335dbfc6f07807c4
https://pubmed.ncbi.nlm.nih.gov/25773571
https://pubmed.ncbi.nlm.nih.gov/25773571
Autor:
Andrea Navarria, Filippo Drago, Giacomo Pignataro, Laura Longo, S. Mansueto, Valentina Drago, Lucia Gozzo
Publikováno v:
Value in Health. (1):131-136
Background Drug costs have risen rapidly in the last decade, driving third-party payers to adopt performance-based agreements that provide either a discount before payment or an ex post reimbursement on the basis of treatments' effectiveness and/or s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dfa09c97362cc5aaf07ad7407dc125f